Program
Docetaxel
Also written as “docetaxel”, “Taxotere” and “HB1801”.
Its studies are mostly in Breast Neoplasms · Carcinoma, Non-Small-Cell Lung · Prostatic Neoplasms · Stomach Neoplasms · Lung Neoplasms, led by 27 companies.
Drug pageDocetaxel: every studyMany companies study it; this page follows only the 142 they lead. All 1,164 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Sanofi | 540 open or running | phase 4since Jan 18, 2006 | Nov 1, 1999 | none ahead |
| Hoffmann-La Rocheits history only | 220 open or running | phase 4since Aug 5, 2005 | Feb 12, 2004 | none ahead |
| CSPC Pharmaceutical Groupits history only | 1511 open or running | phase 3since Apr 20, 2023 | Mar 10, 2021 | Dec 16, 2026phase 3 · NCT06747338 |
| Eli Lillyits history only | 81 open or running | phase 3since Nov 1, 2004 | Nov 1, 2004 | May 2027phase 2 · NCT05999994 |
| Pfizerits history only | 70 open or running | phase 2since Jan 4, 2002 | Jan 4, 2002 | none ahead |
| GlaxoSmithKlineits history only | 60 open or running | phase 2since Jul 17, 2003 | Jul 17, 2003 | none ahead |
| Amgenits history only | 40 open or running | phase 2since Jul 5, 2000 | Jul 5, 2000 | none ahead |
| Merckits history only | 30 open or running | phase 2since Oct 4, 2007 | Oct 4, 2007 | none ahead |
| Novaceaits history only | 30 open or running | phase 3since Aug 9, 2002 | Aug 9, 2002 | none ahead |
| Novartisits history only | 20 open or running | phase 3since Jun 29, 2004 | Jun 29, 2004 | none ahead |
| Samyang Biopharmaceuticalsits history only | 20 open or running | phase 1since Mar 21, 2011 | Mar 21, 2011 | none ahead |
| Academy Military Medical Science, Chinaits history only | 10 open or running | phase 2since Jul 14, 2008 | Jul 14, 2008 | none ahead |
| Chong Kun Dang Pharmaceuticalits history only | 10 open or running | phase 1since Nov 23, 2009 | Nov 23, 2009 | none ahead |
| HealthCare Global Enterpriseits history only | 10 open or running | phase 2since Sep 29, 2016 | Sep 29, 2016 | none ahead |
| Hope Cancer Instituteits history only | 10 open or running | phase 2since Nov 1, 1999 | Nov 1, 1999 | none ahead |
| Ionis Pharmaceuticalsits history only | 10 open or running | phase 2since Nov 2, 2010 | Nov 2, 2010 | none ahead |
| Lidds ABits history only | 10 open or running | phase 1since Mar 18, 2021 | Mar 18, 2021 | none ahead |
| NanOlogyits history only | 10 open or running | phase 1since Feb 5, 2020 | Feb 5, 2020 | none ahead |
| Oshadi Drug Administrationits history only | 10 open or running | phase 2since May 7, 2014 | May 7, 2014 | none ahead |
| Relmada Therapeuticsits history only | 11 open or running | phase 2since Aug 8, 2024 | Aug 8, 2024 | Nov 2027phase 2 · NCT06663137 |
| Sarah Cannon Research Instituteits history only | 10 open or running | phase 2since Jun 27, 2007 | Jun 27, 2007 | none ahead |
| Shanghai Miracogenits history only | 11 open or running | phase 3since Feb 22, 2023 | Feb 22, 2023 | none ahead |
| Simcere Pharmaceutical Groupits history only | 10 open or running | phase 1since May 25, 2020 | May 25, 2020 | none ahead |
| Sumitomo Pharmaits history only | 10 open or running | phase 1since Dec 7, 2020 | Dec 7, 2020 | none ahead |
| Swedish Orphan Biovitrumits history only | 10 open or running | phase 3since Feb 5, 2003 | Feb 5, 2003 | none ahead |
| Zhuhai Beihai Biotechits history only | 11 open or running | phase 2since Dec 9, 2024 | Dec 9, 2024 | none ahead |
| Zivenaits history only | 10 open or running | phase 2since May 11, 2004 | May 11, 2004 | none ahead |
Also a collaborator on its studies: Jazz Pharmaceuticals Ireland, Parexel, Baili-Bio (Chengdu) Pharmaceutical, Clovis Oncology, Astellas Pharma, Exelixis, Gilead Sciences, iTeos Belgium, Intas Pharmaceuticals, Lambda Therapeutic Research, Medigen Biotechnology, US Biotest, Quintiles, MDS Pharma Services, AstraZeneca and Regeneron Pharmaceuticals.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Sanofi only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 39 studies since Nov 1, 1999.
- May 29, 2008Phase 3 study in Breast NeoplasmsNCT00688740 · 1,491 enrolled · United States, Argentina, Austria and more
- Jun 24, 2008Phase 3 study in Prostatic NeoplasmsNCT00705822 · 54 enrolled · Spain
- Jul 24, 2008Phase 2 study in Prostatic NeoplasmsNCT00723086 · 16 enrolled · Japan
- Oct 13, 20082 phase 2 studiesNCT00826852, NCT00772863
- Oct 13, 2008Phase 4 study in Head and Neck NeoplasmsNCT00772681 · 57 enrolled · Turkey
- Dec 18, 2008Phase 3 study in Stomach NeoplasmsNCT00811447 · 243 enrolled · China
- Dec 31, 2008Phase 2 study in Stomach NeoplasmsNCT00816543 · 41 enrolled · Korea, Republic of
- Jan 7, 2009Phase 2 study in Carcinoma, Non-Small-Cell LungNCT00819728 · 35 enrolled · United States
- Jun 5, 2009Phase 2 study in Head and Neck NeoplasmsNCT00916097 · 66 enrolled · Algeria, Morocco, Tunisia
- Dec 22, 2009Phase 3 study in Lung NeoplasmsNCT01038661 · 375 enrolled · China
- Jun 21, 2010Phase 1 study in NeoplasmsNCT01148615 · 20 enrolled · China
- Dec 23, 2010Phase 2 study in Lung NeoplasmsNCT01266512 · 34 enrolled · Hong Kong
- Jan 10, 2012Phase 3 study in Stomach NeoplasmsNCT01515748 · 530 enrolled · Korea, Republic of
- Oct 29, 2012Phase 2 study in Prostate Cancer MetastaticNCT01718353 · 63 enrolled · United States, Canada
TargetBeta
“Tubulin inhibitor; Tubulin stabiliser”ChEMBL 37, by rule
Other programs on the same 15 targets
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Paclitaxelrule | Hoffmann-La Roche | phase 4 | 202 |
| cabazitaxelrule | Sanofi | phase 4 | 21 |
| Vinblastinerule | Takeda | phase 4 | 4 |
| desoxyepothilone Brule | beijing-biostar-pharmaceuticals-co-ltd | phase 3 | 19 |
| plinabulinrule | beyondspring-pharmaceuticals-inc | phase 3 | 8 |
Studies
All 54 Sanofi leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01718353Prostate Cancer Metastatic · United States, Canada | 2 | Completed | Aug 2015 | 63 |
| NCT01515748Stomach Neoplasms · Korea, Republic of | 3 | Completed | Jan 21, 2019 | 530 |
| NCT01266512Lung Neoplasms · Hong Kong | 2 | Completed | Mar 2014 | 34 |
| NCT01148615Neoplasms · China | 1 | Completed | Sep 2011 | 20 |
| NCT01038661Lung Neoplasms · China | 3 | Completed | Aug 2012 | 375 |
| NCT00916097Head and Neck Neoplasms · Algeria, Morocco, Tunisia | 2 | Completed | Nov 2005 | 66 |
| NCT00819728Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | 35 | |
| NCT00816543Stomach Neoplasms · Korea, Republic of | 2 | Completed | May 2012 | 41 |
| NCT00811447Stomach Neoplasms · China | 3 | Completed | Jun 2012 | 243 |
| NCT00826852Lung Neoplasms · Turkey | 2 | Completed | Jul 2009 | 49 |
| NCT00772863Ovarian Neoplasms · Turkey | 2 | Completed | Jun 2008 | 37 |
| NCT00772681Head and Neck Neoplasms · Turkey | 4 | Completed | Mar 2008 | 57 |
| NCT00723086Prostatic Neoplasms · Japan | 2 | Completed | Sep 2008 | 16 |
| NCT00705822Prostatic Neoplasms · Spain | 3 | Terminated | Jul 2009 | 54 |
| NCT00688740Breast Neoplasms · United States, Argentina, Austria and more | 3 | Completed | Jan 2010 | 1,491 |
| NCT00620100Breast Neoplasms · Austria, Poland | 2 | Terminated | Apr 2005 | 2 |
| NCT00617968Breast Neoplasms · France | 2 | Completed | 5 | |
| NCT00565448Nasopharyngeal Neoplasms · Algeria, Brazil, China and more | 2 | Completed | Mar 2009 | 75 |
| NCT00545246Neoplasms · Japan | 1 | Completed | Jul 2012 | 12 |
| NCT00539669Ovarian Neoplasms · Korea, Republic of | 2 | Completed | 47 | |
| NCT00539630Carcinoma, Squamous Cell · Korea, Republic of | 3 | Completed | 86 | |
| NCT00521521Head and Neck Neoplasms · France | 2 | Completed | May 2006 | 86 |
| NCT00514917Prostatic Neoplasms · United States, Belgium, Canada and more | 3 | Terminated | Sep 2012 | 413 |
| NCT00498797Prostatic Neoplasms · Brazil, Germany, Hungary and more | 2 | Completed | Jul 2007 | 86 |
| NCT00494338Prostatic Neoplasms · Brazil | 2 | Terminated | Apr 2005 | 6 |
| NCT00461344Carcinoma, Ductal | 2 | Terminated | Jun 2005 | 20 |
| NCT00436839Prostatic Neoplasms · China | 3 | Completed | Jun 2012 | 228 |
| NCT00436293Nasopharyngeal Neoplasms · Hong Kong | 2 | Completed | Mar 2010 | 61 |
| NCT00432315Carcinoma, Squamous Cell · Austria | 2 | Completed | Oct 2009 | 80 |
| NCT00425191Carcinoma, Non-Small-Cell Lung · Italy | 2 | Completed | Apr 2005 | 165 |
| NCT00424853Carcinoma, Non-Small-Cell Lung · Italy | 2 | Completed | Aug 2008 | 88 |
| NCT00401323Head and Neck Neoplasms · United States, Argentina, Australia and more | 3 | Completed | Jun 2003 | 568 |
| NCT00382720Stomach Neoplasms · United States, Belgium, France and more | 2 | Completed | Apr 2010 | 275 |
| NCT00378573Carcinoma, Non-Small-Cell Lung · United States | 2 | Terminated | Sep 2008 | 17 |
| NCT00365365Breast Neoplasms · United States | 2 | Completed | Oct 2011 | 214 |
| NCT00364611Breast Neoplasms · United States | 2 | Completed | Jun 2011 | 73 |
| NCT00356122Carcinoma, Non-Small-Cell Lung · United States | 2 | Completed | Aug 2010 | 53 |
| NCT00343239Stomach Neoplasms · Turkey | 2 | Completed | Mar 2012 | 59 |
| NCT00312208Breast Neoplasms · United States, Argentina, Australia and more | 3 | Completed | Oct 2008 | 3,299 |
| NCT00296816Ovarian Neoplasms · United States | 2 | Completed | Aug 2011 | 132 |
| NCT00290966Stomach Neoplasms | 3 | Completed | 610 | |
| NCT00283062Prostatic Neoplasms · United States, Australia, Austria and more | 3 | Completed | Dec 2010 | 228 |
| NCT00280098Prostatic Neoplasms · Czech Republic | 4 | Completed | Oct 2007 | 30 |
| NCT00273546Neoplasms · United States, Argentina, Canada and more | 3 | Completed | Feb 2006 | 500 |
| NCT00271323Carcinoma, Non-Small-Cell Lung · France | 2 | Terminated | Feb 2007 | 14 |
| NCT00268710Prostatic Neoplasms | 2 | Completed | Mar 2006 | |
| NCT00268671Head and Neck Neoplasms | 2 | Completed | Apr 2006 | 45 |
| NCT00263016Carcinoma, Non-Small-Cell Lung · Hong Kong | 2 | Terminated | 50 | |
| NCT00258739Lung Neoplasms · Spain | 2 | Completed | Sep 2007 | 140 |
| NCT00174772Lung Neoplasms · Belgium, Finland, France and more | 2 | Completed | Feb 2009 | 72 |
| NCT00174629Lung Neoplasms · Germany, Spain, Switzerland | 3 | Completed | Jan 2007 | 449 |
| NCT00069888Prostatic Neoplasms · United States | 2 | Completed | Jan 2007 | 83 |
| NCT00047840Carcinoma, Non-Small-Cell Lung · United States, Czech Republic, Hungary | 2 | Completed | 129 | |
| NCT00002662Breast Neoplasms · United States | 3 | Completed |
How it is read
Names in the registry
- “Docetaxel”, 93 entries
- “docetaxel”, 37 entries
- “Taxotere”, 9 entries
- “HB1801”, 8 entries
- “Docetaxel for injection (Albumin-bound)”, 4 entries
Codes read as this program: CKD810.
Conditions, from the studies’ own filings
- Breast Neoplasms, 54 studies
- Carcinoma, Non-Small-Cell Lung, 48 studies
- Prostatic Neoplasms, 21 studies
- Stomach Neoplasms, 9 studies
- Lung Neoplasms, 7 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.